filmov
tv
Tycel Phillips, M.D., Shares Research Findings at the 2024 ASCO Annual Meeting
Показать описание
City of Hope's Tycel Phillips, M.D., discusses the promising results from a Phase I/II study on glofitamab for treating relapsed/refractory mantle cell lymphoma. Dr. Phillips presented findings at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
#lymphoma #lymphomaresearch #asco24
Want to learn more about City of Hope’s impact on cancer?
Call us at: 626-256-HOPE (4673)
Stay connected with us on social media:
#lymphoma #lymphomaresearch #asco24
Want to learn more about City of Hope’s impact on cancer?
Call us at: 626-256-HOPE (4673)
Stay connected with us on social media:
0:01:26
0:05:33
0:01:44
0:02:13
0:01:46
0:01:24
0:57:59
0:01:18
0:34:01
0:02:01
0:57:59
1:00:50
1:10:33
1:00:50
0:06:35
0:10:25
0:09:14
0:02:23
1:00:19
0:02:01
0:02:09
0:02:37
0:30:43
0:02:16